Tyrosine kinase inhibitor-induced severe bullous pemphigoid in a patient with advanced stage of liver cancer: a case report and literature review

Y Li, T Wang, M Wang - Authorea Preprints, 2023 - essopenarchive.org
Apatinib, a novel vascular endothelial growth factor receptor-2 (VEGFR2) targeted
chemotherapy for solid tumors, has revealed promising efficacy in treating liver cancer in …